These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
24. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors. Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843 [TBL] [Abstract][Full Text] [Related]
25. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches. Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303 [TBL] [Abstract][Full Text] [Related]
26. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Engelbrecht I; Petzer JP; Petzer A Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942 [TBL] [Abstract][Full Text] [Related]
28. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Novaroli L; Reist M; Favre E; Carotti A; Catto M; Carrupt PA Bioorg Med Chem; 2005 Nov; 13(22):6212-7. PubMed ID: 16054369 [TBL] [Abstract][Full Text] [Related]
35. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies. Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606 [TBL] [Abstract][Full Text] [Related]
36. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues. Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740 [TBL] [Abstract][Full Text] [Related]
37. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase. Nel MS; Petzer A; Petzer JP; Legoabe LJ Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218 [TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach. Mubashir N; Fatima R; Naeem S Curr Comput Aided Drug Des; 2020; 16(4):420-434. PubMed ID: 32883197 [TBL] [Abstract][Full Text] [Related]
39. Isolobetyol, a new polyacetylene derivative from Li W Nat Prod Res; 2022 Jan; 36(1):466-469. PubMed ID: 32573262 [TBL] [Abstract][Full Text] [Related]
40. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]